Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Bond Increases Intra-Agency Liaison Role

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA Director of Scientific Policy Development Susan Bond will assume a greater role in intra-agency communications.

You may also be interested in...

FDA External Relations Head Pitts Will Leave Agency June 18

Associate Commissioner for External Relations Peter Pitts will join the public relations firm Manning, Selvage & Lee as VP-health affairs. During his 14-month tenure at FDA, the agency adopted a more aggressive communications approach.

Crawford Will Lead A Reorganized FDA As McClellan Leaves For CMS

FDA is implementing a three-deputy commissioner structure on an acting basis to ensure a smooth transition. Selection of a permanent commissioner is unlikely before the November elections.

Pink Sheet Podcast: EUA’s Impact On US FDA, March-In Rights, CBER And Real-Time Oncology Review

Pink Sheet reporters and editor discuss the influence of the emergency use authorization on FDA decisions, another twist in the march-in rights debate, and how CBER is not using the real-time oncology review program.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts